CoChat
Sign Up
Cited by 21

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

The Role of Glial Cells and Synapse Loss in Mouse Models of Alzheimer’s Disease

Ziegler-Waldkirch, Stephanie, Meyer-Luehmann, Melanie·2018·Frontiers in Cellular Neuroscience
DOI 10.3389/fncel.2018.00473PMC PMC6297249
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fncel.2018.00473

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Beneficial or detrimental roles of reactive microglia and astrocytes in the degradation of Aβ have been reported, depending on the activation state of these cells.

    “Beneficial or detrimental roles of reactive microglia and astrocytes in the degradation of Aβ have been reported, depending on the activation state of these cells (Meyer-Luehmann et al., 2008; Ziegler-Waldkirch and Meyer-Luehmann, 2018).”

    From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Ziegler-Waldkirch and Meyer-Luehmann, 2018

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 88

  1. Bergles, 2010, Neuron-glia synapses in the brain, Brain Res. Rev., 63, 130, 10.1016/j.brainresrev.2009.12.003 · DOI
  2. Bolmont, 2008, Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance, J. Neurosci., 28, 4283, 10.1523/JNEUROSCI.4814-07.2008 · DOI · Paper page
  3. Brawek, 2014, Impairment of in vivo calcium signaling in amyloid plaque-associated microglia, Acta Neuropathol., 127, 495, 10.1007/s00401-013-1242-2 · DOI
  4. Callahan, 1999, Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles, J. Neuropathol. Exp. Neurol., 58, 275, 10.1097/00005072-199903000-00007 · DOI
  5. Cleary, 2005, Natural oligomers of the amyloid-β protein specifically disrupt cognitive function, Nat. Neurosci., 8, 79, 10.1038/nn1372 · DOI
  6. Cracchiolo, 2007, Enhanced cognitive activity—over and above social or physical activity—is required to protect Alzheimer’s mice against cognitive impairment, reduce Aβ deposition, and increase synaptic immunoreactivity, Neurobiol. Learn. Mem., 88, 277, 10.1016/j.nlm.2007.07.007 · DOI
  7. Crimins, 2011, Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy, Acta Neuropathol., 122, 551, 10.1007/s00401-011-0877-0 · DOI
  8. D’Amore, 2003, In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories, J. Neuropathol. Exp. Neurol., 62, 137, 10.1093/jnen/62.2.137 · DOI · Paper page
  9. Dagher, 2015, Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice, J. Neuroinflammation, 12, 139, 10.1186/s12974-015-0366-9 · DOI · Paper page
  10. Decker, 2010, Amyloid-β peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3β in primary cultured hippocampal neurons, J. Neurosci., 30, 9166, 10.1523/JNEUROSCI.1074-10.2010 · DOI
  11. Dimou, 2015, NG2-glia and their functions in the central nervous system, Glia, 63, 1429, 10.1002/glia.22859 · DOI
  12. Dorostkar, 2014, Immunotherapy alleviates amyloid-associated synaptic pathology in an Alzheimer’s disease mouse model, Brain J. Neurol., 137, 3319, 10.1093/brain/awu280 · DOI
  13. Dudai, 2013, Memorable trends, Neuron, 80, 742, 10.1016/j.neuron.2013.09.039 · DOI
  14. Filser, 2015, Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions, Biol. Psychiatry, 77, 729, 10.1016/j.biopsych.2014.10.013 · DOI
  15. Fowler, 2014, Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer’s disease, J. Neurosci., 34, 7871, 10.1523/JNEUROSCI.4749-14.2014 · DOI
  16. Fuhrmann, 2007, Dendritic pathology in prion disease starts at the synaptic spine, J. Neurosci., 27, 6224, 10.1523/JNEUROSCI.5062-06.2007 · DOI
  17. Fukumoto, 2002, β-secretase protein and activity are increased in the neocortex in Alzheimer disease, Arch. Neurol., 59, 1381, 10.1001/archneur.59.9.1381 · DOI · Paper page
  18. Garcia-Alloza, 2006, Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model, J. Neuropathol. Exp. Neurol., 65, 1082, 10.1097/01.jnen.0000240468.12543.af · DOI · Paper page
  19. Ginsberg, 2000, Expression profile of transcripts in Alzheimer’s disease tangle-bearing CA1 neurons, Ann. Neurol., 48, 77, 10.1002/1531-8249(200007)48:1<77::aid-ana12>3.3.co;2-1 · DOI
  20. Grimaldi, 2018, Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer’s disease in the 3xTg-AD mouse model, Cell Death Dis., 9, 685, 10.1038/s41419-018-0740-5 · DOI
  21. Grundke-Iqbal, 1986, Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology, Proc. Natl. Acad. Sci. U S A, 83, 4913, 10.1073/pnas.83.13.4913 · DOI · Paper page
  22. Grutzendler, 2007, Long-term two-photon transcranial imaging of synaptic structures in the living brain, CSH Protoc., 2007, pdb.prot4766, 10.1101/pdb.prot4766 · DOI
  23. Guerreiro, 2013, TREM2 variants in Alzheimer’s disease, N. Engl. J. Med., 368, 117, 10.1056/NEJMoa1211851 · DOI · Paper page
  24. Haass, 2004, Take five—BACE and the γ-secretase quartet conduct Alzheimer’s amyloid β-peptide generation, EMBO J., 23, 483, 10.1038/sj.emboj.7600061 · DOI
  25. Harper, 1997, Models of amyloid seeding in Alzheimer’s disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins, Annu. Rev. Biochem., 66, 385, 10.1146/annurev.biochem.66.1.385 · DOI · Paper page
  26. Harris, 2010, Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer’s disease are independent of caspase cleavage of the amyloid precursor protein, J. Neurosci., 30, 372, 10.1523/JNEUROSCI.5341-09.2010 · DOI · Paper page
  27. Herring, 2009, Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology, Exp. Neurol., 216, 184, 10.1016/j.expneurol.2008.11.027 · DOI
  28. Hollingworth, 2012, Genome-wide association study of Alzheimer’s disease with psychotic symptoms, Mol. Psychiatry, 17, 1316, 10.1038/mp.2011.125 · DOI
  29. Hu, 2018, BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions, J. Exp. Med., 215, 927, 10.1084/jem.20171831 · DOI
  30. Hyman, 2011, Amyloid-dependent and amyloid-independent stages of Alzheimer disease, Arch. Neurol., 68, 1062, 10.1001/archneurol.2011.70 · DOI
  31. Ittner, 2010, Dendritic function of tau mediates amyloid-β toxicity in Alzheimer’s disease mouse models, Cell, 142, 387, 10.1016/j.cell.2010.06.036 · DOI · Paper page
  32. Jo, 2014, GABA from reactive astrocytes impairs memory in mouse models of Alzheimer’s disease, Nat. Med., 20, 886, 10.1038/nm.3639 · DOI · Paper page
  33. Jonsson, 2013, Variant of TREM2 associated with the risk of Alzheimer’s disease, N. Engl. J. Med., 368, 107, 10.1056/NEJMoa1211103 · DOI · Paper page
  34. Jun, 2010, Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes, Arch. Neurol., 67, 1473, 10.1001/archneurol.2010.201 · DOI · Paper page
  35. Keren-Shaul, 2017, A unique microglia type associated with restricting development of Alzheimer’s disease, Cell, 169, 1276, 10.1016/j.cell.2017.05.018 · DOI · Paper page
  36. Koffie, 2011, Alzheimer’s disease: synapses gone cold, Mol. Neurodegener., 6, 63, 10.1186/1750-1326-6-63 · DOI
  37. Koffie, 2009, Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques, Proc. Natl. Acad. Sci. U S A, 106, 4012, 10.1073/pnas.0811698106 · DOI · Paper page
  38. Krasemann, 2017, The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases, Immunity, 47, 566.e9, 10.1016/j.immuni.2017.08.008 · DOI · Paper page
  39. Kuchibhotla, 2009, Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice, Science, 323, 1211, 10.1126/science.1169096 · DOI · Paper page
  40. Kumar, 2011, Phosphorylation of amyloid β (Aβ) peptides—a trigger for formation of toxic aggregates in Alzheimer’s disease, Aging, 3, 803, 10.18632/aging.100362 · DOI
  41. Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease, Nat. Genet., 41, 1094, 10.1038/ng.439 · DOI · Paper page
  42. Lazarov, 2005, Environmental enrichment reduces Aβ levels and amyloid deposition in transgenic mice, Cell, 120, 701, 10.1016/j.cell.2005.01.015 · DOI · Paper page
  43. Lee, 2010, Channel-mediated tonic GABA release from glia, Science, 330, 790, 10.1126/science.1184334 · DOI
  44. Li, 2009, Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake, Neuron, 62, 788, 10.1016/j.neuron.2009.05.012 · DOI · Paper page
  45. Li, 2011, Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors, J. Neurosci., 31, 6627, 10.1523/JNEUROSCI.0203-11.2011 · DOI
  46. Liebscher, 2012, A peephole into the brain: neuropathological features of Alzheimer’s disease revealed by in vivo two-photon imaging, Front. Psychiatry, 3, 26, 10.3389/fpsyt.2012.00026 · DOI
  47. Liebscher, 2014, Chronic γ-secretase inhibition reduces amyloid plaque-associated instability of pre- and postsynaptic structures, Mol. Psychiatry, 19, 937, 10.1038/mp.2013.122 · DOI
  48. Lin, 2004, Synaptic signaling between neurons and glia, Glia, 47, 290, 10.1002/glia.20060 · DOI
  49. Lucas, 2012, Novel BACE1 inhibitor, E2609, lowers Aβ levels in the cerebrospinal fluid and plasma in nonhuman primates, Alzheimers Dement., 8, P224, 10.1016/j.jalz.2012.05.2022 · DOI
  50. Maletic-Savatic, 1999, Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity, Science, 283, 1923, 10.1126/science.283.5409.1923 · DOI · Paper page
  51. Masliah, 2001, Recent advances in the understanding of the role of synaptic proteins in Alzheimer’s disease and other neurodegenerative disorders, J. Alzheimers Dis., 3, 121, 10.3233/jad-2001-3117 · DOI
  52. Masliah, 1990, Diffuse plaques do not accentuate synapse loss in Alzheimer’s disease, Am. J. Pathol., 137, 1293
  53. May, 2011, Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor, J. Neurosci., 31, 16507, 10.1523/JNEUROSCI.3647-11.2011 · DOI · Paper page
  54. McCarter, 2013, Clustering of plaques contributes to plaque growth in a mouse model of Alzheimer’s disease, Acta Neuropathol., 126, 179, 10.1007/s00401-013-1137-2 · DOI
  55. Meyer-Luehmann, 2009, A reporter of local dendritic translocation shows plaque- related loss of neural system function in APP-transgenic mice, J. Neurosci., 29, 12636, 10.1523/JNEUROSCI.1948-09.2009 · DOI
  56. Mora, 2007, Aging, plasticity and environmental enrichment: structural changes and neurotransmitter dynamics in several areas of the brain, Brain Res. Rev., 55, 78, 10.1016/j.brainresrev.2007.03.011 · DOI
  57. Mucke, 2000, High-level neuronal expression of aβ1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation, J. Neurosci., 20, 4050, 10.1523/JNEUROSCI.20-11-04050.2000 · DOI · Paper page
  58. Nägerl, 2004, Bidirectional activity-dependent morphological plasticity in hippocampal neurons, Neuron, 44, 759, 10.1016/j.neuron.2004.11.016 · DOI · Paper page
  59. Nimmerjahn, 2005, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 308, 1314, 10.1126/science.1110647 · DOI · Paper page
  60. Paolicelli, 2011, Synaptic pruning by microglia is necessary for normal brain development, Science, 333, 1456, 10.1126/science.1202529 · DOI · Paper page
  61. Parkhurst, 2013, Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor, Cell, 155, 1596, 10.1016/j.cell.2013.11.030 · DOI · Paper page
  62. Peters, 2018, BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology, Acta Neuropathol., 135, 695, 10.1007/s00401-017-1804-9 · DOI
  63. Roberson, 2007, Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer’s disease mouse model, Science, 316, 750, 10.1126/science.1141736 · DOI · Paper page
  64. Rogers, 1992, Complement activation and β-amyloid-mediated neurotoxicity in Alzheimer’s disease, Res. Immunol., 143, 624, 10.1016/0923-2494(92)80046-N · DOI
  65. Serrano-Pozo, 2011, Neuropathological alterations in Alzheimer disease, Cold Spring Harb. Perspect. Med., 1, a006189, 10.1101/cshperspect.a006189 · DOI · Paper page
  66. Shankar, 2009, Biochemical and immunohistochemical analysis of an Alzheimer’s disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life, Neurobiol. Dis., 36, 293, 10.1016/j.nbd.2009.07.021 · DOI
  67. Shankar, 2008, Amyloid-β protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory, Nat. Med., 14, 837, 10.1038/nm1782 · DOI · Paper page
  68. Shen, 2001, Complement activation by neurofibrillary tangles in Alzheimer’s disease, Neurosci. Lett., 305, 165, 10.1016/S0304-3940(01)01842-0 · DOI · Paper page
  69. Sofroniew, 2009, Molecular dissection of reactive astrogliosis and glial scar formation, Trends Neurosci., 32, 638, 10.1016/j.tins.2009.08.002 · DOI · Paper page
  70. Spires-Jones, 2009, Tau pathophysiology in neurodegeneration: a tangled issue, Trends Neurosci., 32, 150, 10.1016/j.tins.2008.11.007 · DOI
  71. Stelzmann, 1995, An English translation of Alzheimer’s 1907 paper, “Über eine eigenartige Erkankung der Hirnrinde”, Clin. Anat., 8, 429, 10.1002/ca.980080612 · DOI · Paper page
  72. Stephan, 2012, The complement system: an unexpected role in synaptic pruning during development and disease, Annu. Rev. Neurosci., 35, 369, 10.1146/annurev-neuro-061010-113810 · DOI · Paper page
  73. Stevens, 2007, The classical complement cascade mediates CNS synapse elimination, Cell, 131, 1164, 10.1016/j.cell.2007.10.036 · DOI · Paper page
  74. Terry, 1991, Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol., 30, 572, 10.1002/ana.410300410 · DOI · Paper page
  75. Tremblay, 2010, Preparation of mouse brain tissue for immunoelectron microscopy, J. Vis. Exp., 41, e2021, 10.3791/2021 · DOI
  76. Vassar, 2014, BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease, Alzheimers Res. Ther., 6, 89, 10.1186/s13195-014-0089-7 · DOI
  77. Verkhratsky, 2010, Astrocytes in Alzheimer’s disease, Neurother. J. Am. Soc. Exp. Neurother., 7, 399, 10.1016/j.nurt.2010.05.017 · DOI
  78. Walsh, 2002, Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo, Nature, 416, 535, 10.1038/416535a · DOI · Paper page
  79. Wang, 2014, Postsynaptic target specific synaptic dysfunctions in the CA3 area of BACE1 knockout mice, PLoS One, 9, e92279, 10.1371/journal.pone.0092279 · DOI
  80. Wisniewski, 1991, Spatial relationships between astrocytes and classical plaque components, Neurobiol. Aging, 12, 593, 10.1016/0197-4580(91)90091-w · DOI · Paper page
  81. Woo, 2012, TREK-1 and Best1 channels mediate fast and slow glutamate release in astrocytes upon GPCR activation, Cell, 151, 25, 10.1016/j.cell.2012.09.005 · DOI
  82. Yan, 2014, Targeting the β secretase BACE1 for Alzheimer’s disease therapy, Lancet Neurol., 13, 319, 10.1016/S1474-4422(13)70276-X · DOI
  83. Yang, 2017, Large soluble oligomers of amyloid β-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate, J. Neurosci., 37, 152, 10.1523/JNEUROSCI.1698-16.2016 · DOI · Paper page
  84. Zhan, 2014, Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior, Nat. Neurosci., 17, 400, 10.1038/nn.3641 · DOI · Paper page
  85. Zhao, 2007, β-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer’s disease pathogenesis, J. Neurosci., 27, 3639, 10.1523/JNEUROSCI.4396-06.2007 · DOI · Paper page
  86. Zhu, 2018, Consequences of pharmacological BACE inhibition on synaptic structure and function, Biol. Psychiatry, 84, 478, 10.1016/j.biopsych.2018.04.022 · DOI
  87. Ziegler-Waldkirch, Seed-induced Aβ deposition is modulated by microglia under environmental enrichment in a mouse model of Alzheimer’s disease, EMBO J., 37, 167, 10.15252/embj.201797021 · DOI
  88. Ziegler-Waldkirch, Environmental enrichment reverses Aβ pathology during pregnancy in a mouse model of Alzheimer’s disease, Acta Neuropathol. Commun., 6, 44, 10.1186/s40478-018-0549-6 · DOI

Cited by

Sorted by citations

Metadata

Authors
Ziegler-Waldkirch, S., & Meyer-Luehmann, M.
Venue
Frontiers in Cellular Neuroscience
Publisher
Frontiers Media SA
Published
2018-12-11
Volume
12
ISSN
1662-5102
DOI
10.3389/fncel.2018.00473
PMC
PMC6297249
Cited by
21
References
35
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)
Funders
Deutsche Forschungsgemeinschaft

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review